Search clinical trials for: Macugen

Total 209 results

Pfizer
ITEC GROUP 3

Completed

Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions

Macular Degeneration

France
Greater Houston Retina Research

Withdrawn

A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy (No-Crunch01)

Proliferative Diabetic Retinopathy

United States
Valley Retina Institute

Completed

Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study (PRESERVE)

Diabetic Macular Edema

United States
Palmetto Retina Center, LLC
Pfizer; Eyetech Pharmaceuticals

Completed

Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

United States
Lawson Health Research Institute
Pfizer

Completed

Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) (PEGAP001)

Diabetic Macular Edema | Proliferative Diabetic Retinopathy

Canada
Klinikum Ludwigshafen
Pfizer

Unknown

Subretinal Macugen® for Neovascular Age-Related Macular Degeneration

Age-related Macular Degeneration

Germany
Pfizer

Completed

Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

Macular Degeneration

Greece, Italy, Slovakia, Spain, Sweden, Czech Republic, Germany, Belgium, France, Cyprus, Denmark, Ireland, Poland
L.V. Prasad Eye Institute
Pfizer

Withdrawn

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia (INGECT)

Myopic Choroidal Neovascular Membrane

India
Retina Institute of Hawaii
Eyetech Pharmaceuticals

Available

A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema (GUARDIAN)

Diabetic Macular Edema

United States
Retina Institute of Hawaii

Completed

A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy

PDR

United States
Eyetech Pharmaceuticals

Completed

Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula

Diabetic Macular Edema
Pfizer

Completed

Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration

Macular Degeneration
Eyetech Pharmaceuticals
Pfizer

Unknown

A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD

Age-Related Macular Degeneration (AMD)

United States
Eyetech Pharmaceuticals
Pfizer

Completed

Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration
Bausch & Lomb Incorporated

Completed

Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium

Age-Related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion

United States
Pfizer

Completed

A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Macular Edema Associated With Diabetes Mellitus

United States, Colombia, Australia, Germany, Italy, South Africa, Greece, France, Austria, United Kingdom, Denmark, India, Portugal, Brazil, Canada, Czechia, Netherlands, Switzerland
Valley Retina Institute
Pfizer

Unknown

Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)

Proliferative Diabetic Retinopathy

United States
Johns Hopkins University
Eyetech Pharmaceuticals

Terminated

Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics

Cystoid Macular Edema

United States
Johns Hopkins University
Eyetech Pharmaceuticals

Terminated

The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema

Cystoid Macular Edema

United States
Eyetech Pharmaceuticals
Pfizer

Completed

Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)

Macular Degeneration
Wake Forest University

Completed

Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema

Uveitis | Cystoid Macular Edema

United States
University of Oxford
Pfizer

Completed

Intravitreal Macugen for Ischaemic Diabetic Macular Oedema (MIDME)

Diabetic Macular Oedema

United Kingdom
Pfizer

Withdrawn

Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.

Neovascular Age-related Macular Degeneration
Pfizer

Completed

A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life. (MACURELI)

Neovascular Age-related Macular Degeneration

Belgium
Hermann Eye Center
Eyetech Pharmaceuticals

Completed

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

Diabetic Retinopathy | Iris Neovascularization

United States
Kerecis Ltd.

Completed

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Pressure Ulcers | Venous Ulcers | Trauma-related Wound | Diabetic Ulcers | Chronic Ulcer of Foot

Iceland
Eyetech Pharmaceuticals
Pfizer

Terminated

Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

United States
Eisai Inc.

Completed

Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Leukemia

United States
Luca Cardone
University of Pisa; Azienda Ospedaliera Universitaria Integrata Verona; Catholic... and other collaborators

Recruiting

tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr (ORIENTATE)

Pancreatic Adenocarcinoma Metastatic | Pancreatic Adenocarcinoma Recurrent

Italy
The Cleveland Clinic

Completed

Hypotension Prediction Index for Blood Pressure Management (HPI)

Intraoperative Hypotension

United States
Kerecis Ltd.

Completed

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Punch Biopsy Wounds | Healing Times

Iceland
University of Utah
Eisai Inc.

Completed

Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients

Acute Myeloid Leukemia | AML

United States
Washington University School of Medicine
Cephalon

Completed

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Myelodysplastic Syndromes and Leukemia, Myeloid, Acute

United States
University Hospital Dubrava

Completed

Use of Hypotension Prediction Index to Reduce Intraoperative Hypotension in Major Thoracic Surgery

Hypotension During Surgery

Croatia
Seoul National University Hospital
MACROGEN

Unknown

Cancer Panel From Blood of Lung Cancer Patients (CAPABLE)

Non Small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer Recurrent

Korea, Republic of
Edwards Lifesciences

Unknown

Hypotension Prediction Index Study (HPI Study)

Hypotension

United States
Chang Gung Memorial Hospital

Recruiting

Hypotension Prediction Index in Patients Undergoing Liver Transplantation

Intraoperative Hypotension

Taiwan
The Ludwig Boltzmann Institute of Retinology and...

Completed

MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen

Macular Degeneration

Austria
Fondazione Policlinico Universitario Agostino Gemelli...

Not yet recruiting

Impact of Using an Hemodynamic Monitoring System on Anesthetic Consumption During Abdominal Surgery (HERMES)

Hypotension During Surgery
Elevar Therapeutics

Terminated

A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Korea, Republic of
Geertrui Dewinter

Recruiting

Hypotension Prediction Index for Shoulder Surgery in Beach Chair.

Hypotension During Surgery

Belgium
Kerecis Ltd.
MedStar Health

Completed

Fish Skin Compared to Cadaver Skin as Temporary Cover for Full Thickness Burns (Kereburn)

Burns

United States
Edwards Lifesciences

Active, not recruiting

SMART TRENDS Study

Moderate to High-risk Noncardiac Surgery

United States
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

Hypotension Prediction Index in Postoperative Surgical Patients (HPI-PACU)

Surgery

Canada
Kagawa University

Recruiting

Cohort Study of the Clinical Course of Macular Diseases in Kagawa

Macular Disease

Japan
Eisai Inc.

Completed

Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States
Eisai Inc.

Completed

Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Eisai Inc.

Completed

A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes

Myelodysplastic Syndrome

United States, Canada
Jianxiang Wang
Xian-Janssen Pharmaceutical Ltd.

Unknown

Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients

Untreated Adult Acute Myeloid Leukemia | Effect of Drugs | Drug Safety
King's College London
King's College Hospital NHS Trust

Unknown

Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure (DEC-MDS)

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome

United Kingdom

3

Subscribe